Current:Home > MyJoe Rogan signs new multiyear Spotify deal that allows him to stream on other services -WealthMindset Learning
Joe Rogan signs new multiyear Spotify deal that allows him to stream on other services
View
Date:2025-04-16 20:22:50
Spotify has signed a new multiyear deal with Joe Rogan that will allow the hit podcaster to air his program on competing platforms, the streaming company announced Friday.
"The Joe Rogan Experience," which had aired exclusively on Spotify, will also soon be available on streaming services including Apple, Amazon and YouTube, the company said. The show "remains podcasting's king, consistently ranking as the most-listened-to podcast globally," the company said in a statement.
Spotify declined to comment on the terms of the deal. A Wall Street Journal report said the contract could be worth up $250 million over the life of the contract.
Beyond his ability to air his show on other venues, Rogan will also receive a share of the revenue generated by his program, according to the newspaper, which cited people familiar with the terms.
Known for giving a platform to conspiracy theories, Rogan and Spotify were accused of spreading misinformation about COVID-19 during the pandemic, prompting some musicians to pull their work from the service.
Rogan has also hosted a range of high-profile figures, from scientist Neil deGrasse Tyson to Senator Bernie Sanders, creating more than 2,200 episodes that average two to three hours in length.
"I only have people on the show that I'm genuinely interested in talking to. I never do a podcast just because a person is popular. It's always from a place of 'I think it would be cool to talk to that person'," Rogan wrote in a Spotify blog post.
Spotify has more than 574 million users. Shares of Spotify were lately up 1.3% at $221.81, in keeping with market gains overall.
- In:
- Joe Rogan
- Spotify
Kate Gibson is a reporter for CBS MoneyWatch in New York.
veryGood! (1)
Related
- House passes bill to add 66 new federal judgeships, but prospects murky after Biden veto threat
- Tabitha Brown's Final Target Collection Is Here— & It's All About Having Fun in the Sun
- Kendall Jenner and Bad Bunny's Latest Date Night Proves They're In Sync
- Minnesota Groups Fear Environmental Shortcuts in Enbridge’s Plan to Rebuild Faulty Pipeline
- Intel's stock did something it hasn't done since 2022
- Proof Matty Healy Is Already Bonding With Taylor Swift’s Family Amid Budding Romance
- See How Kaley Cuoco, Keke Palmer and More Celebs Are Celebrating Mother's Day 2023
- Bernie Sanders on Climate Change: Where the Candidate Stands
- In ‘Nickel Boys,’ striving for a new way to see
- It’s Not Just Dakota Access. Many Other Fossil Fuel Projects Delayed or Canceled, Too
Ranking
- How to watch the 'Blue Bloods' Season 14 finale: Final episode premiere date, cast
- Kit Keenan Shares The Real Reason She’s Not Following Mom Cynthia Rowley Into Fashion
- Treat Williams, star of Everwood and Hair, dead at 71 after motorcycle crash in Vermont: An actor's actor
- At least 1.7 million Americans use health care sharing plans, despite lack of protections
- The FTC says 'gamified' online job scams by WhatsApp and text on the rise. What to know.
- Travis Barker's Kids Send Love to Stepmom Kourtney Kardashian on Mother's Day
- In Trump, U.S. Puts a Climate Denier in Its Highest Office and All Climate Change Action in Limbo
- Ryan Shazier was seriously injured in an NFL game. He has advice for Damar Hamlin
Recommendation
The city of Chicago is ordered to pay nearly $80M for a police chase that killed a 10
Saudi Arabia’s Solar Ambitions Still Far Off, Even With New Polysilicon Plant
China's COVID vaccines: Do the jabs do the job?
Saudi Arabia’s Solar Ambitions Still Far Off, Even With New Polysilicon Plant
North Carolina trustees approve Bill Belichick’s deal ahead of introductory news conference
The FDA approves an Alzheimer's drug that appears to modestly slow the disease
Get Budge-Proof, Natural-Looking Eyebrows With This 44% Off Deal From It Cosmetics
Is it time for a reality check on rapid COVID tests?